Ultrastructural injury of arterial endothelium. 3. Effects of enzymes and surfactants.
D000681:Amylases / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000473:pathology*; D001647:Bile Acids and Salts / Q000494:pharmacology; D002462:Cell Membrane; D010450:Endopeptidases / Q000494:pharmacology; D004798:Enzymes / Q000494:pharmacology*; D004848:Epithelium / Q000473:pathology; D005341:Fibrinolysin / Q000494:pharmacology; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology; D007083:Iliac Artery / Q000473:pathology; D007269:Injections, Intra-Arterial; D008049:Lipase / Q000494:pharmacology; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D008297:Male; D003012:Microbial Collagenase / Q000494:pharmacology; D008854:Microscopy, Electron; D009439:Neuraminidase / Q000494:pharmacology; D010105:Oxygenases / Q000494:pharmacology; D010196:Pancreatic Elastase / Q000494:pharmacology; D010206:Papain / Q000494:pharmacology; D010740:Phospholipases / Q000494:pharmacology; D051381:Rats; D013501:Surface-Active Agents / Q000494:pharmacology*; D014688:Venoms / Q000494:pharmacology
D001647:Bile Acids and Salts; D004798:Enzymes; D008244:Lysophosphatidylcholines; D013501:Surface-Active Agents; D014688:Venoms; D010105:Oxygenases; D010740:Phospholipases; D008049:Lipase; D000681:Amylases; D009439:Neuraminidase; D006821:Hyaluronoglucosaminidase; D010450:Endopeptidases; D010196:Pancreatic Elastase; D005341:Fibrinolysin; D010206:Papain; D003012:Microbial Collagenase